title: The effect of C5a and U46619 on the isolated, perfused human placental lobule: development of a method for the online estimation of tissue fluid accumulation.
abstract: A method for the automatic and simultaneous determination of perfusion pressure and fluid accumulation in the isolated, perfused human placental lobule is described. We demonstrated that the inflammatory mediator, C5a, a C5a agonist analogue peptide, and the thromboxane mimetic U46619 caused increased fetal perfusion pressure and increased tissue weight when administered via the fetal arterial circulation. Occlusion of the fetal venous effluent tubing caused significantly greater increases in tissue weight than the pharmacological agents. Detectable increases in tissue weight occurred within 47 +/- 3 sec (n = 21) following pressure increases caused by the pharmacological agents. In each case, the increase in tissue weight was accompanied by an increased permeability of the materno-fetal barrier, shown by the transfer of Evans blue albumin from the fetal circulation to the maternal compartment.
authors.affiliation: Placental Laboratory, Mater Misericordiae Hospital, South Brisbane, Australia.
authors.forename: A M
authors.initials: AM
authors.lastname: Finch
authors.forename: A E
authors.initials: AE
authors.lastname: Heron
authors.forename: S L
authors.initials: SL
authors.lastname: Tolhurst
authors.forename: T H
authors.initials: TH
authors.lastname: Florin
authors.forename: S D
authors.initials: SD
authors.lastname: Sanderson
authors.forename: S M
authors.initials: SM
authors.lastname: Taylor
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000418:Albumins / Q000737:chemistry / Q000378:metabolism; D000595:Amino Acid Sequence; D000704:Analysis of Variance; D001826:Body Fluids / Q000187:drug effects / Q000378:metabolism; D015936:Complement C5a / Q000494:pharmacology*; D005070:Evans Blue / Q000737:chemistry; D005321:Extraembryonic Membranes / Q000187:drug effects; D005260:Female; D006801:Humans; D008969:Molecular Sequence Data; D009862:Online Systems; D009929:Organ Size; D010477:Perfusion; D010920:Placenta / Q000187:drug effects* / Q000378:metabolism; D011247:Pregnancy; D011312:Pressure; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000031:analogs & derivatives* / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
chemical_list: D000418:Albumins; D011450:Prostaglandin Endoperoxides, Synthetic; D014662:Vasoconstrictor Agents; D005070:Evans Blue; D013928:Thromboxane A2; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D015936:Complement C5a